Skip to main content
SpringerLink
Log in

Analgesic-associated nephropathy

  • Übersicht
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Although the question of whether or not analgesic abuse leads to a certain type of nephropathy has been investigated since 1953, no conclusive answer has been forthcoming. Epidemiologic investigations on the correlation between analgesic abuse and renal function as well as experimental animal studies have given contradictory results concerning the possibility of analgesic-associated kidney damage. However, studies on the correlation between analgesic abuse and papillary necrosis have demonstrated that this lesion coincides in 69% of the cases with an analgesic history. Follow-up studies of patients with analgesic nephropathy have shown that renal function deteriorates in 60% of the patients with continued abuse and that it stabilizes in 80% of the patients after cessation of abuse. Studies on the legislative restriction of phenacetin/acetaminophen, carried out mostly in Scandinavian countries since 1965, show a 50%–90% decline in signs of analgesic nephropathy (papillary necrosis) following a reduction in the sale of these drugs. The prevalence of analgesic abuse may be underestimated, since up to 80% of the abusers tend to deny their analgesic intake. Obviously, only a small percentage of analgesic abusers (approximately 1%) finally develop nephropathy. Even though the results of epidemiologic and experimental studies are contradictory, the results of investigations on papillary necrosis and on legislative prevention as well as of patient follow-ups tend to indicate a correlation between analgesic abuse and a well-defined type of nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AAN:

analgesic-associated nephropathy

AA:

analgesic abuse

PN:

renal papillary necrosis

References

  1. Abel JA (1971) Analgesic nephropathy — a review of the literature. Clin Pharmacol Ther 12:583–598

    PubMed  Google Scholar 

  2. Abrahams C (1976) Cause of analgesic-induced renal papillary necrosis. Lancet II:346–347

    Google Scholar 

  3. Abrahams C (1979) More on the pathology of analgesic abuse. N Engl J Med 301:437–438, 1979

    Google Scholar 

  4. Abrahams C, Furman KI (1978) Analgesic abuse and microvascular changes. Am Heart J 95:268–269

    PubMed  Google Scholar 

  5. Abrahams C, Levin NW (1967) Experimentally induced analgesic nephropathy; its pathogenesis. Med Proc 13:506–514

    Google Scholar 

  6. Abrahams C, Rubenstein AH, Levin NW (1963) Phenacetin-induced papillary damage in experimental animals. Nature 200:695–696

    PubMed  Google Scholar 

  7. Abrahams C, Levin NW, Gecelter L, Rubenstein AH (1967) The diagnosis of analgesic nephropathy by renal biopsy. Med Proc 13:501–506

    Google Scholar 

  8. Abrahams C, Van Tonder H, Hesse V (1976) Abnormal vessels in the urinary tract following analgesic abuse in man. Arch Pathol Lab Med 100:630–631

    PubMed  Google Scholar 

  9. Adams DH, Howie AJ, Miachael J, McConkey B, Bacon PA, Adu D (1986) Non-steroidal anti-inflammatory drugs and renal failure. Lancet I:57–60

    Google Scholar 

  10. Alvarez AS, Sammerskill WHJ (1958) Gastrointestinal hemorrhage and salicylates. Lancet II:920–925

    Google Scholar 

  11. Anderson RJ, Berl T, McDonald KM, Schrier RW (1976) Prostaglandins: effects on blood pressure, renal blood flow, sodium and water excretion. Kindey Int 10:205–215

    Google Scholar 

  12. Angervall L, Lehmann l, Lincoln K (1962) Induction of interstitial nephritis in rats fed phenacetin and NAPA (N-acetyl-p-aminophenol). Acta Pathol Microbiol Scand [A] 54:274–282

    Google Scholar 

  13. Angervall L, Bengtsson U, Zetterlund CG, Zsigmond M (1969) Renal pelvic carcinoma in a Swedish district with abuse of a phenacetin-containing drug. Br J Urol 41:401–405

    PubMed  Google Scholar 

  14. Arbeitsgemeinschaft für Klinische Nephrologie (1986) Rundtischgespräch Analgetika-Nephropathie; dürfen wir Nephrologen uns mit der weiteren Verwendung von Phenacetin abfinden? Mitteilungen der Arbeitsgemeinschaft für Klinische Nephrologie BRD und West-Berlin 15 (in press)

  15. Arzneimittelkommission der deutschen Ärzteschaft (1985) Wie lange noch Phenacetin? Dtsch Ärztebl 82:3084

    Google Scholar 

  16. Arnold L, Collins C, Starmer GA (1973) The short-term effects of analgesics on the kidney with special reference to acetylsalicyclic acid. Pathology 5:123–134

    PubMed  Google Scholar 

  17. Axelson RA (1973) Spontaneous renal papillary necrosis in the Gunn rat. Pathology 5:43–50

    PubMed  Google Scholar 

  18. Axelsen RA (1976) Analgesic-induced renal papillary necrosis in the Gunn rat: the comparative nephrotoxicity of aspirin and phenacetin. J Pathol 120:145–150

    PubMed  Google Scholar 

  19. Axelsen RA, Burry AF (1972) Papillary necrosis in the Gunn rat: rapid induction by analgesics. Pathology 4:225–229

    PubMed  Google Scholar 

  20. Axelsson U (1958) Papillitis necroticans renalis och hemolytisk anemi hos fenzonmissbrukare. Nord Med 59:903–904

    PubMed  Google Scholar 

  21. Bach PH, Bridges JW (1984) The role of metabolic activation of analgesic and non-steroidal anti-inflammatory drugs in the development of renal papillary necrosis and upper urothelial carcinoma. Prostaglandins Leukotrienes Med 15:251–274

    Google Scholar 

  22. Bach PH, Hardy TLL (1985) Relevance of animal models to analgesic-associated renal papillary necrosis in humans. Kidney Int 28:605–613

    PubMed  Google Scholar 

  23. Bell D, Kerr DNS, Swinney S, Yeates WK (1969) Analgesic nephropathy; clinical course after withdrawal of phenacetin. Br Med J 3:378–382

    PubMed  Google Scholar 

  24. Bender WL, Whelton A, Beschorner WE, Darwish MO, Hall-Craggs M, Solez K (1984) Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs; immunologic characterization of the inflammatory drugs. Am J Med 76:1006–1012

    PubMed  Google Scholar 

  25. Bengtsson U (1962) A comparative study of chronic nonobstructive pyelonephritis and renal papillary necrosis. Acta Med Scand 172 (Suppl) 388

    Google Scholar 

  26. Bengtsson U (1974) Phenacetin and renal pelvis carcinoma. Clin Nephrol 2:123–126

    PubMed  Google Scholar 

  27. Bengtsson U, Angervall L, Ekman H, lehmann L (1968) Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol 2:145–150

    PubMed  Google Scholar 

  28. Bengtsson U, Johansson S, Angervall L (1978) Malignancies of the urinary tract and their relation to analgesic abuse. Kidney Int 13:107–113

    PubMed  Google Scholar 

  29. Blohmé I, Johansson S (1981) Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy. Kidney Int 20:671–675

    PubMed  Google Scholar 

  30. Bluemle LW, Goldberg JM (1968) Renal accumulation of salicylate and phenacetin: possible mechanisms in the nephropathy of analgesic abuse. J Clin Invest 47:2507–2513

    Google Scholar 

  31. Bock HE (1957) Zur Klinik der Therapieschäden. Dtsch Med Wochenschr 82:1889–1892

    PubMed  Google Scholar 

  32. Bock KD (1983) Die Analgetika-Nephropathie. Nieren-Hockdruckkrh 12:319–326

    Google Scholar 

  33. Bock KD, Hogrefe J (1972) Analgetika-Abusus and maligne Tumoren der ableitenden Harnwege. Münch Med Wochenschr 114:645–652

    Google Scholar 

  34. Bock KD, Nitzsche T (1976) Laxantienabusus, Plasma-Kalium und chronische interstitielle Nephritis durch Phenacetinabusus. Klin Wochenschr 54:239–241

    PubMed  Google Scholar 

  35. Bock KD, Nitzsche T (1984) Häufig, aber vermeidbar; Nierenschaden durch Schmerzmittel. Med Klin 79:308–314

    Google Scholar 

  36. Bock KD, Nitzsche T, Messer B (1973) Chronische interstitielle Nephritis bei langjährigem Gebrauch phenacetinhaltiger Asthmapulver. Dtsch Med Wochenschr 98:2234–2238

    PubMed  Google Scholar 

  37. Bokelman DL, Bagdon WJ, Jensen RD, Zwickey RE (1972) Aspirin: three-month oral toxicity studies in dogs and rats. Toxicol Appl Pharmacol 22:333

    Google Scholar 

  38. Brezin J, Katz SM, Schwartz AB, Chinitz JL (1979) Reversible renal failure and nephrotic syndrome associated with non-steroidal anti-inflammatory drugs. N Engl J Med 301:1271–1273

    PubMed  Google Scholar 

  39. Brod J (1967) Infektionswege bei Pyelonephritis. In: Loose H, Kienitz M (eds) Pyelonephritis — Forschungsergebnisse 1966. Thieme, Stuttgart, p 5

    Google Scholar 

  40. Brunner FP, Richtmann L, Thiel G, Dubach UC (1978) Tumoren der ableitenden Harnwege und Analgetika-Abusus. Schweiz Med Wochenschr 108:1013–1019

    PubMed  Google Scholar 

  41. Brynger H, Brunner FP, chantler C, Donckerwolcke RA, Jacobs C, Kramer P, Sewood NH, Wing AJ (1980) Combined report on regular dialysis and transplantation in Europe, X, 1979. Proc Eur Dial Transplant Assoc 17:4–87

    Google Scholar 

  42. Bundesgesundheitsamt (1986) Phenacetinhaltige Schmerzmittel vom Markt genommen. BGA Pressedienst 6

  43. Burry AF (1968) The evolution of analgesic nephropathy. Nephron 5:185–201

    PubMed  Google Scholar 

  44. Burry AF (1978) Pathology of analgesic nephropathy: Australian experience. Kidney Int 13:34–40

    PubMed  Google Scholar 

  45. Burry AF, de Jersey J, Weedon D (1966) Phenacetin and renal papillary necrosis: results of a prospective autopsy investigation. Med J Aust 1:873–879

    Google Scholar 

  46. Burry AF, Axelsen RA, Trolove P (1974) Analgesic nephropathy: its present contribution to the renal mortality and morbidity profile. Med J Aust 1:31–36

    Google Scholar 

  47. Calder C, Funder CC, Green CR, Ham KN, Tange JD (1971) Comparative nephrotoxicity of aspirin and phenacetin derivates. Br Med J 4:518–521

    PubMed  Google Scholar 

  48. Carmichael J, Shankel SW (1985) Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med 78:992–1000

    PubMed  Google Scholar 

  49. Caterson R, Duggin GG, Horvath J, Mohandas J, Tiller D (1978) Aspirin, protein transacetylation and inhibition of prostaglandin synthetase in the kidney. Br J Pharmacol 64:353–358

    PubMed  Google Scholar 

  50. Clausen E, Harvald B (1961) Nephrotoxicity of different analgesics. Acta Med Scand 170:469–474

    PubMed  Google Scholar 

  51. Clausen E (1962) Nephrotoxic effect of phenacetin and acetylsalicylic acid in animal experiments. Acta Med Scand 172:419–426

    PubMed  Google Scholar 

  52. Clausen E (1964) Histological changes in rabbit kidneys induced by phenacetin and acetylsalicylic acid. Lancet II:123–124

    Google Scholar 

  53. Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310:563–572

    PubMed  Google Scholar 

  54. Consensus Conference (1984) Analgesic-associated kidney disease. JAMA 251:3123–3125

    Google Scholar 

  55. Cove-Smith JR (1981) Analgesic nephropathy in the United Kingdom: incidence, clinical features and pathogenesis. J Clin Pathol 34:1255–1260

    PubMed  Google Scholar 

  56. Craig JM, Fernando VP, Fellers FX, Yaffe S (1961) Renal lesions and electrolyte compositions in experimental salicylate intoxications; increased mortality with added diamox. Fed Proc 20:409

    PubMed  Google Scholar 

  57. Cullen KJ, Woodings T (1975) Alcohol, tobacco and analgesics — Busselton, 1972. Med J Aust 2:211–214

    PubMed  Google Scholar 

  58. Dawborn JK, Fairley KF, Kincaid-Smith P, King WE (1966) The association of peptic ulceration, chronic renal disease, and analgesic abuse. Q J Med 35:69–83

    PubMed  Google Scholar 

  59. DePalma J, Wassermiller J, Akuburah A (1975) Phenacetin/aspirin nephritis as a cause of chronic renal disease. In: Abstracts of the Western Dialysis Transplantation Meeting

  60. Disney APS, Row PG, and a Subcommittee of the Australian Kidney Foundation (1974) Australian maintenance dialysis survey. Med J Aust 2:651–656

    PubMed  Google Scholar 

  61. Door RJM, Croughs A, Le Poole EN, Ten Bokkel Huinink SA (1962) Interstitiele nephritis waarschijnlijk door het gebruik van fenacetine. Ned Tijdschr Geneeskd 106:1899–1902

    PubMed  Google Scholar 

  62. Dubach UC (1981) Die Bedeutung des Analgetikaabusus für chronische Harntraktinfektionen. Therapiewoche 31:7890–7898

    Google Scholar 

  63. Dubach UC (1982) Die Analgetikanephropathie (=AN). Therap Umsch 39:351–359

    Google Scholar 

  64. Dubach UC, Schoen H (1980) Einnahme phenazetinhaltiger Analgetika von Insassen in Altersheimen. Praxis 69:456–459

    Google Scholar 

  65. Dubach UC, Levy PS, Minder F (1968) Epidemiologic study of analgesic intake and its relationship to urinary tract disorders in Switzerland. Helv Med Acta 34:297–312

    PubMed  Google Scholar 

  66. Dubach UC, Rosner B, Pfister E (1983) Epidemiologic study of abuse of analgesics containing phenacetin; renal morbidity and mortality (1968–1979). N Engl J Med 308:357–362

    PubMed  Google Scholar 

  67. Duggan JM (1974) The analgesic syndrome. Aust NZ J Med 4:365–372

    Google Scholar 

  68. Duggin GG (1980) Mechanisms in the development of analgesic nephropathy. Kidney Int 18:553–561

    PubMed  Google Scholar 

  69. Eckey P (1962) Nierenschädigung nach Phenazetinabusus. Z Gesamte Inn Med 17:1046–1050

    Google Scholar 

  70. Eder H (1964) Chronic toxicity studies of phenacetin, N-acetyl-p-aminophenol (NAPA) and acetylsalicylic acid on cats. Acta Pharmocol Toxicol (Copenh) 21:97–204

    Google Scholar 

  71. Eisalo A, Talanti S (1961) Observations on the effect of phenacetin and N-acetyl-p-aminophenol on rat kidneys. Acta Med Scand 169:655–660

    PubMed  Google Scholar 

  72. Ferguson I, Johnson F, Reay B, Wigley R (1977) Aspirin, phenacetin, and the kidney; a rheumatism clinic study. Med J Aust 1:950–984

    PubMed  Google Scholar 

  73. Filipp G, Koenen G (1959) Klinischer Beitrag zum Problem der sogenannten Tablettennephritis. Med Klin 54:1165–1169

    PubMed  Google Scholar 

  74. Finkelstein A, Fraley DS, Stachura I, Feldman HA, Gandy DR, Bourke E (1982) Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis; a possible T-lymphocyte disorder. Am J Med 72:81–87

    PubMed  Google Scholar 

  75. Finnigan D, Burry AF, Smith IDB (1974) Analgesic consumption in an antenatal clinic survey. Med J Aust 1:761–762

    PubMed  Google Scholar 

  76. Fisher LC (1933) Chronic acetanilid poisoning. JAMA 100:736–737

    Google Scholar 

  77. Forsberg L (1960) Fenacetin och acetanilid som orsak till intern-medicinska problem i Värmland. Nord Med 63:223

    Google Scholar 

  78. Fournier A, Andrejak M, Makdassi R, Fievet P, Sebert JL (1986) Accidents rénaux des anti-inflammatoires non stéroidiens. Presse Med 15:777–779

    PubMed  Google Scholar 

  79. Friedreich N von (1877) Über Necrose der Nierenpapillen bei Hydronephrose. Virchows Arch [A] 69:308

    Google Scholar 

  80. Furman KI, Galasko GTF, Meyers AM, Rabkin R (1976) Post-transplantation analgesic dependence in patients who formerly suffered from analgesic nephropathy. Clin Nephrol 5:54–57

    PubMed  Google Scholar 

  81. Garella S, Matarese RA (1984) Renal effects of prostaglandins and clinical adverse effects of non-steroidal anti-inflammatory agents. Medicine 63:165–181

    PubMed  Google Scholar 

  82. Gault MH (1975) The clinical course of patients with analgesic nephropathy. Can Med Assoc J 113:204–207

    PubMed  Google Scholar 

  83. Gault MH, Wilson R (1978) Analgesic nephropathy in Canada: clinical syndrome, management and outcome. Kidney Int 13:58–63

    PubMed  Google Scholar 

  84. Gault MH, Rudwal TC, Redmond NI (1968) Analgesic habits of 500 veterans: incidence and complications of abuse. Can Med Assoc J 98:619–626

    PubMed  Google Scholar 

  85. Gault MH, Rudwal TC, Engles WD, Dossetor JB (1968) Syndrome associated with the abuse of analgesics. Ann Intern Med 68:906–925

    PubMed  Google Scholar 

  86. Gault MH, Blennerhasst J, Muehrcke RC (1971) Analgesic nephropathy; a clinicopathologic study using electron microscopy. Am J Med 51:740–756

    PubMed  Google Scholar 

  87. Gawallek F (1958) Über die Phenacetinintoxikationen. Z Gesamte Inn Med 13:41–46

    Google Scholar 

  88. Geismar P (1971) Dodeligheten af pyelonephritis i Danmark 1957–1967 — i relation til fenacetinforbruget. Ugeskr Laeger 133:550–554

    PubMed  Google Scholar 

  89. George A (1972) Survey of drug use in a Sydney suburb. Med J Aust 2:233–237

    Google Scholar 

  90. Gillies MA, Skyring AP (1972) The pattern and prevalence of aspirin ingestion as determined by interview of 221 inhabitants of Sydney. Med J Aust 1:974–979

    PubMed  Google Scholar 

  91. Gilman A (1964) Analgesic nephrotoxicity; a pharmacological analysis. Am J Med 36:167–173

    PubMed  Google Scholar 

  92. Gloor F (1962) Phenacetinabusus und Nierenschädigung. Schweiz Med Wochenschr 92:61–67

    PubMed  Google Scholar 

  93. Gloor FJ (1965) Some morphologic features of chronic interstitial nephritis (chronic pyelonephritis) in patients with analgesic abuse. In: Kass EH (ed) Progress in pyelonephritis. Philadelphia, Davis, pp 287–296

  94. Gloor F (1978) Changing concepts in pathogenesis and morphology of analgesic nephropathy as seen in Europe. Kidney Int 13:27–33

    PubMed  Google Scholar 

  95. Goldberg M, Murray TG (1978) Analgesic-associated nephropathy; an important cause of renal disease in the United States? N Engl J Med 299:716–717

    PubMed  Google Scholar 

  96. Goldberg M, Myers CL, Peshel W, McCarron D, Morrison AB (1971) Mechanism of analgesic abuse nephropathy. J Clin Invest 50:37a

    Google Scholar 

  97. Gonwa TA, Corbett WT, Schey HM, Buckalew VM (1980) Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract. Ann Intern Med 93:249–252

    PubMed  Google Scholar 

  98. Gonwa TA, Hamilton RW, Buckalew VM (1981) Chronic renal failure and end-stage renal disease in north-west Carolina, importance of analgesic-associated nephropathy. Arch Intern Med 141:462–466

    PubMed  Google Scholar 

  99. Green CR, Ham KN, Tange JD (1969) Kidney lesions induced in rats by p-aminophenol. Br Med J 1:162–164

    PubMed  Google Scholar 

  100. Grimlund K (1963) Phenacetin and renal damage at a Swedish factory. Acta Med Scand 174 (Suppl) 405:1–26

    Google Scholar 

  101. Gsell O (1974) Nephropathie durch Analgetica. Ergeben Inn Med Kinderheilk 35:67–175

    Google Scholar 

  102. Gsell O, Rechenberg v HK, Miescher P (1957) Die primär chronische interstitielle Nephritis; klinische, experimentelle und aetiologische Untersuchungen. Dtsch Med Wochenschr 82:1673–1676

    PubMed  Google Scholar 

  103. Gsell O, Rechenberg v HK, Miescher P (1957) II. Die Pathogenese der interstitiellen Nephritis. Dtsch Med Wochenschr 82:1718–1726

    PubMed  Google Scholar 

  104. Gsell O, Rechenberg v K, Miescher P (1958) Probleme der chronischen interstitiellen Nephritis. Schweiz Med Wochenschr 88:389–390

    Google Scholar 

  105. Harrow BR, Sloane JA, Liebman NC (1963) Renal papillary necrosis and analgesics; roentgen differentiation from sponge kidney and other diseases. JAMA 184:445–452

    PubMed  Google Scholar 

  106. Harvald B (1963) Renal papillary necrosis; a clinical survey of sixty-six cases. Am J Med 35:481–486

    PubMed  Google Scholar 

  107. Harvald B, Nielsen A (1960) Effect on the kidney of drugs containing phenacetin. Lancet I:303–305

    Google Scholar 

  108. Headache cures (1978) In: the lone hand (1907, pp 193–195), reprinted in: Nanra RS, Stuart-Taylor J, de Leon AH, White KH, analgesic nephropathy, etiology, clinical syndrome, and clinicopathologic correlations in Australia. Kidney Int 13:79–92

    Google Scholar 

  109. Hengstmann H (1962) Mißbrauch phenacetinhaltiger Schmerzmittel und Nierenschädigung. Med Welt 10:529–532

    PubMed  Google Scholar 

  110. Hengstmann H (1966) Über Verbreitung und Folgen des Phenazetin-Abusus auf dem Lande; ein Bericht über 70 Fälle. Münch Med Wochenschr 108:1489–1393

    Google Scholar 

  111. Hennessy BL, Bruen WJ, Cullen J (1973) The Canberry Mental Health survey; preliminary results. Med J Aust 1:721–728

    PubMed  Google Scholar 

  112. Hensler L (1957) Die chronisch-interstitielle Nephritis. Dtsch Med Wochenschr 82:202–207

    PubMed  Google Scholar 

  113. Hesse VE, van Tonder H, Abrahams C (1976) Analgesic cystitis: an unusual microangiopathy of the bladder. J Urol 116:176–177

    PubMed  Google Scholar 

  114. Höffler D, Bittner B, Fiegel P, Köhler H (1973) Phenacetin-Niere; Symptomatik und Verlauf bei 53 Patienten. Dtsch Med Wochenschr 98:2012–2016

    PubMed  Google Scholar 

  115. Hofvander Y (1964) Hedbergs pulver-phenacetinskador i en kommun i norra Angermanland. Svenska Läkartid 61:1705–1709

    Google Scholar 

  116. Hood B, Falkheden T, Carlsson M (1967) Trends and present pattern of mortality in chronic uremia. Acta Med Scand 181:561–569

    PubMed  Google Scholar 

  117. Horisberger B, Grandjean E, Lanz F (1958) Untersuchungen über den Medikamentenmißbrauch in einem Großbetrieb der schweizerischen Uhrenindustrie. Schweiz Med Wochenschr 38:920–926

    Google Scholar 

  118. Hultengren N (1964) Renal papillary necrosis; a clinical study of 103 cases. Acta Chir Scand (Suppl) 277:7–84

    Google Scholar 

  119. Hultengren N, Lagergren C, Lungqvist A (1965) Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir Scand 130:314–320

    PubMed  Google Scholar 

  120. Jacobs LA, Morris JG (1962) Renal papillary necrosis and the abuse of phenacetin. Med J Aust 2:531–538

    Google Scholar 

  121. Jaeger P, Burckhard P, Wauters JP (1982) Calcium metabolism in analgesic abuse nephropathy. In: Norman AW, Schaefer K, Herrath v D, Grigoleit H-G (eds), Vitamin D-chemical, biochemical and clinical endocrinology of calcium metabolism. De Gruyter, Berlin-New York, pp 1013–1015

    Google Scholar 

  122. Jasinski B (1948) Über zwei Fälle von toxischer, hämolytischer ischer Anämie nach Phenacetin resp. Sulfonamiden mit Bildung intraglobulärer, pathologischer Blutfarbstoffderivate vom Typus der Verdohämochromogene resp. des Verdoglobins = Sulfhämoglobin. Schweiz Med Wochenschr 78:681–684

    Google Scholar 

  123. Jasinski B, Müller D (1950) Zur Pathogenese der toxischhämolytischen Anämien nach chronischem Phenacetinabusus. Schweiz Med Wochenschr 80:681–684

    PubMed  Google Scholar 

  124. Jasinski B, Wuhrmann F (1958) Zur Frage der Schäden infolge Phenacetinabusus. Schweiz Med Wochenschr 88:1290–1292

    PubMed  Google Scholar 

  125. Johansson S, Wahlqvist L (1977) Tumours of urinary bladder and ureter associated with abuse of phenacetin-containing analgesics. Acta Pathol Microbiol Scand [A] 85:768–774

    Google Scholar 

  126. Johansson S, Angervall L, Bengtsson U, Wahlqvist L (1974) Uroepithelial tumors of the renal pelvis associated with abuse of phenacetin-containing analgesics. Cancer 33:743–753

    PubMed  Google Scholar 

  127. Kärber G (1950) Was geschieht bei uns gegen den Schlafmittelmißbrauch? Dtsch Med Wochenschr 75:1479–1480

    PubMed  Google Scholar 

  128. Kaladelfos G, Edwards KDG (1976) Increased prevalence of coronary heart disease in analgesic nephropathy: relation to hypertension, hypertriglyceridaemia and combined hyperlipidaemia. Nephron 16:388–400

    PubMed  Google Scholar 

  129. Kasanen A, Salmi HA (1961) The use of phenacetin and its detrimental effects on a series of hospital patients. Ann Med Int Fenniae 50:195–204

    Google Scholar 

  130. Kasanen A, Forsström J, Salmi HA (1962) On the commonness, causes and detrimental effects of the use of analgesics by factory workers and hospital patients. Acta Med Scand 172:15–19

    PubMed  Google Scholar 

  131. Kassis V, Kassis E (1978) Nyrepapilnekrose og fenacetinforbrug. Ugeskr Laeger 140:1406–1407

    PubMed  Google Scholar 

  132. Keller F, Schwarz A (1983) Analgesic dilemma in chronic hemodialysis patients. Pain 17:99–101

    PubMed  Google Scholar 

  133. Keller HM, Cottier H, Reubi F (1961) Fehlen von Nierenveränderungen nach Colibazilleninjektionen bei mit Phenacetin chronisch behandelten Kaninchen. Schweiz Med Wochenschr 91:1021–1025

    Google Scholar 

  134. Kielholz P (1954) Ätiologie und Therapie der Analgetica- und Hypnoticasucht. Schweiz Med Wochenschr 84:753–756

    PubMed  Google Scholar 

  135. Kielholz P (1957) Abusus und Sucht mit phenacetinhaltigen Kombinationspräparaten. Schweiz Med Wochenschr 87:1131–1134

    PubMed  Google Scholar 

  136. Kielholz P, Battegay R (1967) Vergleichende Untersuchungen Über die Genese und den Verlauf der Drogenabhängigkeit und des Alkoholismus. Schweiz Med Wochenschr 97:893–898

    PubMed  Google Scholar 

  137. Kimberly RP, Plotz PH (1977) Aspirin-induced depression of renal function. N Engl J Med 296:418–424

    PubMed  Google Scholar 

  138. Kimberly RP, Bowden RE, Keiser HR, Plotz PH (1978) Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med 64:804–807

    PubMed  Google Scholar 

  139. Kincaid-Smith P (1963) The association between chronic renal disease, peptic ulceration, and analgesic abuse. 2nd Int Congress of Nephrology. Excerpta Medica International Congress Series 67:91

    Google Scholar 

  140. Kincaid-Smith P (1967) Pathogenesis of the renal lesion associated with the abuse of analgesics. Lancet I:859–862

    Google Scholar 

  141. Kincaid-Smith P (1968) Phenacetin. Lancet II:717–718

    Google Scholar 

  142. Kincaid-Smith P (1968) Analgesic nephropathy. Ann Intern Med 68:949–953

    PubMed  Google Scholar 

  143. Kincaid-Smith P (1969) Analgesic nephropathy, a common form of renal disease in Australia. Med J Aust 2:1131–1135

    PubMed  Google Scholar 

  144. Kincaid-Smith P (1978) Analgesic nephropathy. Kidney Int 13:1–4

    PubMed  Google Scholar 

  145. Kincaid-Smith P (1979) Analgesic nephropathy in Australia. Contrib Nephrol 16:57–64

    PubMed  Google Scholar 

  146. Kincaid-Smith P (1980) Analgesic abuse and the kidney. Kidney Int 17:250–260

    PubMed  Google Scholar 

  147. Kincaid-Smith P (1984) Analgesic nephropathy in Australia (1959–1984). In: Analgeisc nephropathy; epidemiology — pathology — prevention. Symposium, University of Antwerp

  148. Kincaid-Smith P, Saker BM, McKenzie IFC, Muriden KD (1968) Lesions in the blood supply of the papilla in experimental analgesic nephropathy. Med J Aust 1:203–206

    PubMed  Google Scholar 

  149. Kingsley DPE, Goldberg B, Abrahams C, Meyers AJ, Furman KI, Cohen I (1972) Analgesic nephropathy. Br Med J 4:656–659

    PubMed  Google Scholar 

  150. Kjaerluff J, Harvald B (1968) Incidence of papillitis necroticans. Nord Med 80:1588–1590

    PubMed  Google Scholar 

  151. Knapp M, Avioli LV (1982) Analgesic nephropathy. Arch Intern Med 142:1197–1199

    PubMed  Google Scholar 

  152. Krikler DM (1967) Paracetamol and the kidney. Br Med J 2:615–616

    PubMed  Google Scholar 

  153. Koch KM (1984) Der Analgetikaabusus und seine renalen Risiken; ein Problem der internistischen Schmerzbehandlung. Therapiewoche 34:3672–3679

    Google Scholar 

  154. König U (1974) Anwendung von Analgetika und Psychopharmaka bei bekanntem Phenazetinabusus. Schweiz Med Wochenschr 104:997–1001

    PubMed  Google Scholar 

  155. Koutsimanis KG, Wardener HE (1970) Phenacetin nephropathy, with particular reference to the effect of surgery. Br Med J 4:131–134

    PubMed  Google Scholar 

  156. Krishnaswamy S, Nanra RS (1976) “Phenacetin” nephropathy without phenacetin. Aust NZ J Med 6:88

    Google Scholar 

  157. Krishnaswamy S, Wallace D, Nanra RS (1974) Ischaemic heart disease in analgesic nephropathy. Aust NZ J Med 4:426–427

    Google Scholar 

  158. Krishnaswamy S, Wallace D, Nanra RS (1974) Ischaemic heart disease in analgesic nephropathy. Aust NZ J Med 4:426–427

    Google Scholar 

  159. Kyle ME, Kocsis JJ (1985) The effect of age on salicylate-induced nephrotoxicity in male rats. Toxicol Appl Pharmacol 81:337–347

    PubMed  Google Scholar 

  160. Lakey WH (1961) Interstitial nephritis due to chronic phenacetin poisoning. Can Med Assoc J 85:477–479

    PubMed  Google Scholar 

  161. Landmann-Suter R, Dubach UC (1975) Phenacetin and Nierenschädigung; Verlaufskontrolle bei langjährigem Schmerzmittelgebrauch. Dtsch Med Wochenschr 100:1451–1456

    PubMed  Google Scholar 

  162. Larsen K, Moeller CE (1959) A renal lesion caused by abuse of phenacetin. Acta Med Scand 164:53–71

    PubMed  Google Scholar 

  163. Lavan JN, Benson WJ, Gatenby AH, Posen S (1966) the consumption of analgesics by Australian hospital patients. Med J Aust 2:694–695

    PubMed  Google Scholar 

  164. Lawson DH (1973) Analgesic consumption and impaired renal function. J Chron Dis 26:39–45

    PubMed  Google Scholar 

  165. Leistenschneider W, Nagel R, Steffens J (1983) Nierenbeckentumoren und Phenacetinabusus; eigene Ergebnisse und Literaturübersicht. Acta Urol Belg 14:15–20

    Google Scholar 

  166. Leschke E (1955) Die wichtigsten Vergiftungen (Lehmann (ed), München 1933). In: Schweingruber R, Probleme der chronischen Vergiftungen mit kombinierten Phenacetinpräparaten. Schweiz Med Wochenschr 85:1162–1166

    PubMed  Google Scholar 

  167. Levin NW, Rubenstein AH, Abrahams C, Jordaan JC, Posel MM (1962) Phenacetin nephritis; interstitial nephritis and necrotizing papillitis associated with the chronic ingestion of phenacetin. S Afr Tydskr Geneesk 36:555–559

    Google Scholar 

  168. Lindeneg O, Fischer S, Pedersen J, Nissen NI (1959) Necrosis of the renal papillae and prolonged abuse of phenacetin. Acta Med Scand 165:321–323

    PubMed  Google Scholar 

  169. Lindvall N (1960) Renal papillary necrosis; a roentgenographic study of 155 cases. Acta Radiol (Stockh) [Suppl 192]:1–153

    PubMed  Google Scholar 

  170. Linton AL (1972) Renal disease due to analgesics. Can Med Assoc J 107:749–751

    PubMed  Google Scholar 

  171. Lorenzen I, Schwartz M (1960) Phenacetin-induced haemolysis in patients with chronic nephritis and phenacetin abuse. Acta Med Scand 168:461–466

    PubMed  Google Scholar 

  172. Lornoy W, Morelle V, Becaus I, Fonteyne E, Vrouwziekenhus OL (1979) Analgesic nephropathy. N Engl J Med 300:319–320

    PubMed  Google Scholar 

  173. Mabeck CE, Wichmann B (1979) Mortality from chronic interstitial nephritis and phenacetin consumption in Denmark. Acta Med Scand 205:599–601

    PubMed  Google Scholar 

  174. Maher JF (1984) Analgesic nephropathy; observations, interpretations, and perspective on the low incidence in America. Am J Med 76:345–348

    PubMed  Google Scholar 

  175. Mandel EE (1952) Renal medullary necrosis. Am J Med 13:322–327

    PubMed  Google Scholar 

  176. Masshoff W, Hollmann G (1962) Die interstitielle Nephritis. Internist 3:629–640

    PubMed  Google Scholar 

  177. Mayer P (1966) Nierenschädigung durch Phenacetinabusus; ein Beitrag zur Diagnostik, Klinik und Therapie. Med Welt 46:2484–2486

    PubMed  Google Scholar 

  178. McAnally JF, Winchester JF, Schreiner GE (1983) Analgesic nephropathy; an uncommon cause of end-stage renal disease. Arch Intern Med 143:1897–1899

    PubMed  Google Scholar 

  179. McCredie M, Ford JM, Taylor JS, Stewart JH (1982) Analgesics and cancer of the renal pelvis in New South Wales. Cancer 49:2617–2625

    PubMed  Google Scholar 

  180. McCredie M, Stewart JH, Mahony JF (1982) Is phenacetin responsible for analgesic nephropathy in New Youth Wales? Clin Nephrol 17:134–140

    PubMed  Google Scholar 

  181. McCutcheon AD (1962) Renal damage and phenacetin. Med J Aust 2:543–546

    Google Scholar 

  182. McIver MA, Hobbs JB (1975) The failure of high doses of aspirin to produce renal lesions in pigs. Med J Aust 1:197–199

    PubMed  Google Scholar 

  183. Miescher P, Schnyder U, Krech U (1958) Zur Pathogenese der “interstitiellen Nephritis” bei Abusus phenacetinhaltiger Analgetika. Schweiz Med Wochenschr 88:432–437

    PubMed  Google Scholar 

  184. Miescher P, Studer A (1961) Weitere tierexperimentelle Untersuchungen zur Frage der Pathogenese der interstitiellen Nephritis. Schweiz Med Wochenschr 91:939–943

    Google Scholar 

  185. Mihatsch MH, Torhorst J, Amsler B (1978) Capillarosclerosis of the lower urinary tract in analgesic (phenacetin) abuse; an electron microscopic study. Virchows Arch [A] 381:41–47

    Google Scholar 

  186. Mihatsch MJ, Hofer HO, Gutzwiler F, Brunner FP, Zooinger HU (1980) Phenacetinabusus I. Häufigkeit, Pro-Kopf-Verbrauch und Folgekosten. Schweiz Med Wochenschr 110:108–115

    PubMed  Google Scholar 

  187. Mihatsch MJ, Manz T, Knüsli C, Hofer HO, Rist J, Guetg R, Rutishauser G, Zollinger HU (1980) Phenacetinabusus III. Maligne Harnwegtumoren bei Phenaectinabusus in Basel 1963–1977. Schweiz Med Wochenschr 110:255–264

    PubMed  Google Scholar 

  188. Mihatsch MJ, Schmidlin P, Brunner FP, Hofer HO, Six P, Zolinger HU (1980) Phenacetinabusus II; die chronische renale Niereninsuffizienz im Basler Autopsiegut. Schweiz Med Wochenschr 110:116–124

    PubMed  Google Scholar 

  189. Mihatsch MJ, Brunner FP, Korteweg E, Rist M, Dalquen P, Thiel G (1982) Phenacetinabusus VII: Harnwegtumoren bei Dialysepatienten und Nierentransplantatträgern. Schweiz Med Wochenschr 112:1468–1472

    PubMed  Google Scholar 

  190. Mihatsch MJ, Hofer HO, Korteweg E, Zollinger HU (1982) Phencetinabusus V: Häufigkeit der Phenacetinabuser im Baseler Autopsiegut 1978–1980. Schweiz Med Wochenschr 112:1245–1248

    PubMed  Google Scholar 

  191. Mihatsch MJ, Knüsli C (1982) Phenacetin abuse and malignant tumors; an autopsy study covering 25 years (1953–1977). Klin Wochenschr 60:1339–1349

    PubMed  Google Scholar 

  192. Mihatsch MJ, Kernen R, Zollinger HU (1982) Phenacetinabusus VI: Eine Autopsiestatistik unter besonderer Berücksichtigung extrarenaler Befunde. Schweiz Med Wochenschr 112:1383–1388

    PubMed  Google Scholar 

  193. Mihatsch MJ, Hofer HO, Gudat F, Knüsli C, Torhorst J, Zollinger HU (1983) Capillary sclerosis of the urinary tract and analgesic nephropathy. Clin Nephrol 20:285–301

    PubMed  Google Scholar 

  194. Mihatsch MJ, Saehelin HB, Musfeld D, Perret E, Oberholzer M (1983) Phenacetin-Abusus: Kardiovaskuläre Risikofaktoren. Nieren- und Hochdruckkr 12:83–92

    Google Scholar 

  195. Moeller J, Heiland A (1959) Sekundäre Niereninsuffizienz, interstitielle Nephritis oder tubuläre Insuffizienz bei Phenacetinabusus. Dtsch Med Wochenschr 84:1865–1868

    PubMed  Google Scholar 

  196. Moench A (1958) Phenacetinabusus und Nierenschädigung. Dtsch Med Wochenschr 83:664–665

    PubMed  Google Scholar 

  197. Moeschlin S (1957) Phenacetinsucht und -schäden; Innenkörperanämien und interstitielle Nephritis. Schweiz Med Wochenschr 87:123–128

    PubMed  Google Scholar 

  198. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller DJ (1984) Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney; possible implications in analgesic nephropathy. Biochem Pharmacol 33:1801–1807

    PubMed  Google Scholar 

  199. Molland EA (1978) Experimental renal papillary necrosis. Kidney Int 13:5–14

    PubMed  Google Scholar 

  200. Morgan TN, Anderson AG (1940) Chronic acetanilide poisoning. Br Med J 2:187–188

    Google Scholar 

  201. Mudge GH, Gemborys MW, Duggin GG (1978) Covalent binding of metabolites of acetaminophen to kidney protein and depletion of renal glutathion. J Pharmacol Exp Ther 206:218–226

    PubMed  Google Scholar 

  202. Müller T, Kielholz P (1957) Erhebung über Ausmaß, Verbreitung und Prophylaxe des Medikamenten-, insbesondere des Analgetica-Mißbrauchs in der Schweiz. Bull Eidg Gesundheitsamt B 5

  203. Murray RM (1972) Analgesic nephropathy: removal of phenacetin from proprietary analgesics. Br Med J 4:131–132

    PubMed  Google Scholar 

  204. Murray RM (1974) Personality factors in analgesic nephropathy. Psychol Med 4:69–73

    PubMed  Google Scholar 

  205. Murray RM (1978) Genesis of analgesic nephropathy in the United Kingdom. Kidney Int 13:50–57

    PubMed  Google Scholar 

  206. Murray TG, Goldberg M (1975) Chronic intersitital nephritis: etiologic factors. Ann Intern Med 82:453–459

    PubMed  Google Scholar 

  207. Murray RM, Timbury GC, Linton AL (1970) Analgesic abuse in psychiatric patients. Lancet I:1303–1305

    Google Scholar 

  208. Murray RM, Lawson DH, Linton AL (1971) Analgesic nephropathy: clinical syndrome and prognosis. Br Med J 1:479–482

    PubMed  Google Scholar 

  209. Murray TG, Stolley PD, Anthony JC, Schinnar R, Hepler-Smith E, Jeffreys JL (1983) Epidemiologic study of regular analgesic use and end-stage renal disease. Arch Intern Med 143:1687–1693

    PubMed  Google Scholar 

  210. Nachtwey W, Rimpau A (1963) Zur Frage der chronischen interstitiellen Nephritis im Gefolge eines Abusus phenazetinhaltiger Tabletten. Med Klin 58:985–990

    Google Scholar 

  211. Nanra RS (1980) Clinical and pathological aspects of analgesic nephropathy. Br J Clin Pharmacol 10:359S-368S

    PubMed  Google Scholar 

  212. Nanra RS, Kincaid-Smith P (1970) Papillary necrosis in rats caused by aspirin and aspirin-containing mixtures. Br Med J 3:559–561

    PubMed  Google Scholar 

  213. Nanra RS, Kincaid-Smith P (1975) Renal papillary necrosis in rheumatoid arthritis. Med J Aust 1:194–197

    PubMed  Google Scholar 

  214. Nanra RS, Chirawong P, Kincaid-Smith P (1971) Renal papillary necrosis in rats produced by aspirin, APC and other analgesics. In: Kincaid-Smith P, Fairlex KF (eds) Renal infection and renal scarring, pp 347–358

  215. Nanra RS, Chirawong P, Kincaid-Smith P (1973) Medullary ischaemia in experimental analgesic nephropathy — the pathogenesis of renal papillary necrosis. Aust NZ J Med 3:580–586

    Google Scholar 

  216. Nanra RS, Stuart-Taylor J, de Leon AH, White KH (1978) Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia. Kidney Int 13:79–92

    PubMed  Google Scholar 

  217. New Zealand Rheumatism Association Study (1974) Aspirin and the kidney. Br Med J 1:593–596

    Google Scholar 

  218. Nitzsche T, Bock KD (1970) Verlaufsbeobachtungen bei Kranken mit Nephropathie nach Analgetika-Abusus. Dtsch Med Wochenschr 95:927–934

    PubMed  Google Scholar 

  219. Nordenfelt O (1972) Deaths from renal failure in abusers of phenacetin-containing drugs. Acta Med Scand 191:11–15

    PubMed  Google Scholar 

  220. Nordenfelt O, Ringertz N (1961) Phenacetin takers dead with renal failure; 27 men and 3 women. Acta Med Scand 170:385–402

    PubMed  Google Scholar 

  221. Nordensen NG (1958) Fenacetinförgiftningens symtomatologie i anslutning till tre fall. Opusc Med 3:119–120

    Google Scholar 

  222. Nordic Statistics on Medicines 1978–1980 (1982) Nordic Council of Medicine (ed). Uppsala, Sweden, part II, pp 131–137

  223. Olafssson O, Gudmundsson KR, Brekkan A (1966) Migraine, gastritis and renal papillary necrosis; a syndrome in chronic nonobstructive pyelonephritis. Acta Med Scand 179:121–128

    PubMed  Google Scholar 

  224. Panzram G, Müller KH (1964) Ambulante Untersuchungen und klinische Erfahrungen über die Häufigkeit des Analgetikamißbrauches. Dtsch Gesundh 19:903–907

    Google Scholar 

  225. Pendreigh DM, Heasman MH, Howitt LF, Kennedy AC, Mac Dougall JA, Mac Leod M, Robson JS, Stewart WK (1972) Survey of chronic renal failure in Scotland. Lancet I:304–307

    Google Scholar 

  226. Pense G, Fiehring H, Panzram G, Lorenz B (1960) Nil nocere: Ursachen und Folgen des Phenazetinmißbrauchs bei 11 Patienten. Münch Med Wochenschr 102:683–687

    Google Scholar 

  227. Philips BM, Hartnagel RE, Leeling JL, Gurtoo HL (1976) Does apsirin play a role in analgesic nephropathy? Aust NZ J Med [Suppl 1] 6:48–50

    Google Scholar 

  228. Piper JM, Tonascia J, Matanowski G (1985) Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. N Engl J Med 313:292–295

    PubMed  Google Scholar 

  229. Pletscher A (1958) Über die Toxikologie des Phenacetins. Bull Schweiz Akad Med Wiss 14:100–110

    PubMed  Google Scholar 

  230. Pletscher A, Studer A, MIescher P (1958) Experimentelle Untersuchungen über Erythrocyten- und Organveränderungen durch N-Acetyl-p-aminophenol und Phenacetin. Schweiz Med Wochenschr 88:1214–1216

    PubMed  Google Scholar 

  231. Porpaczy P, Schmidt W (1973) Mehrjährige Verlaufskontrolle bei urologischen Patienten mit Phenacetinabusus. In: Egermann H (ed) International phenacetin symposium, Vienna, p 185

  232. Porpaczy P, Schramek P (1981) Analgesic nephropathy and phenacetin-induced transitional cell carcinoma — analysis of 300 patients with long-term consumption of phenacetin-containing drugs. Eur Urol 7:349–354

    PubMed  Google Scholar 

  233. Prescott LF (1965) Effects of acetylsalicylic acid, phenacetin, paracetamol, and caffeine on renal tubular epithelium. Lancet II:91–96

    Google Scholar 

  234. Prescott LF (1966) Analgesic abuse and renal disease in north-east Scotland. Lancet II:1143–1145

    Google Scholar 

  235. Prescott LF (1980) Hepatotoxicity of mild analgesics. Br J Clin Pharmacol 10:373S-379S

    PubMed  Google Scholar 

  236. Prescott LF (1982) Analgesic nephropathy/: a reassessment of the role of phenacetin and other analgesics. Drugs 23:75–149

    PubMed  Google Scholar 

  237. Purnell J, Burry AF (1967) Analgesic consumption in a country town. Med J Aust 2:389–391

    Google Scholar 

  238. Rapoport A, Ranking GN (1962) Renal damage associated with chronic phenacetin overdosage. Ann Intern Med 57:970–980

    PubMed  Google Scholar 

  239. Reubi MF (1954) Le diagnostique de la pyélonephrite chronique J Urol (Paris) 60:816–830

    Google Scholar 

  240. Ross P (1962) A.P.C. as a cause of renal disease. Med J Aust 2:539–543

    Google Scholar 

  241. Roth JLA, Valdes-Dapena A, Piese P, Buchman E (1963) Topical action of salicylates in gastrointestinal erosion and hemorrhage. Gastroenterol 44:146–158

    Google Scholar 

  242. Saker BM, Kincaid-Smith P (1969) Papillary necrosis in experimental analgesic nephropathy. Br Med J 1:161–162

    Google Scholar 

  243. Sarre H (1958) Zur Frage der toxischen Nierenschädigung bei chronischem Phenacetinabusus in Deutschland. Bull Schweiz Akad Med Wiss 14:131–133

    PubMed  Google Scholar 

  244. Sarre H, Rogal U (1964) Nierenerkrankung bei Phenacetinabusus. Dtsch Med Wochenschr 89:2269–2274

    PubMed  Google Scholar 

  245. Sauter A (1958) Der Analgetikamißbrauch als Problem des öffentlichlichen Gesundheitswesens. Bull Schweiz Akad Med Wiss 14:93–99

    PubMed  Google Scholar 

  246. Schaub F, Bühlmann A, Maier C (1953) Nebenerscheinungen und Folgen des chronischen Phenacetinabusus. Schweiz Med Wochenschr 27:626–629

    Google Scholar 

  247. Schreiner GE (1962) The nephrotoxicity of analgesic abuse. Ann Intern Med 57:1047–1052

    PubMed  Google Scholar 

  248. Schumann G, Lickint F (1959) Über Phenacetinabusus und seine Folgen, zugleich ein kasuistischer Beitrag zur sogenannten Phenacetin-Nephritis. Dtsch Gesundh 14:348–352

    Google Scholar 

  249. Schwarz A, Faber U, Borner K, Keller F, Offermann G, Molzahn M (1984) Reliability of drug history in analgesic users. Lancet II:1163–1164

    Google Scholar 

  250. Schwarz A, Pommer W, Kühn-Freitag G, Keller F, Molzahn M, Offermann G (1985) Merkmale der terminalen Analgetika-Nephropathie. Schweiz Med Wochenschr 115:790–795

    PubMed  Google Scholar 

  251. Schwarz A, Faber U, Glaeske G, Keller F, Offermann G (1986) Analgesic nephropathy in West Germany. Lancet I:210

    Google Scholar 

  252. Schweingruber R (1955) Probleme der chronischen Vergiftung mit kombinierten Phenacetinpräparaten. Schweiz Med Wochenschr 85:1162–1166

    PubMed  Google Scholar 

  253. Scott JT, Denman AM, Dorling J (1963) Renal irritation caused by salicylates. Lancet I:344–348

    Google Scholar 

  254. Shelley JH (1967) Phenacetin, through the looking glass. Clin Pharmacol Ther 8:427–471

    PubMed  Google Scholar 

  255. Shelley JH (1978) Pharmacological mechanisms of analgesic nephropathy. Kidney Int 13:15–26

    PubMed  Google Scholar 

  256. Sillanpäa M, Kasanen A, Kelonen A (1982) Changes of panorama in renal disease mortality in Finland after phenacetin restriction. Acta Med Scand 212:313–317

    PubMed  Google Scholar 

  257. Solisch P (1964) Phenazetinkonkrementbildung und chronisch-interstitielle Nephritis bei Phenazetinabusus. Zentralbl Allg Pathol 105:379–385

    PubMed  Google Scholar 

  258. Sorensen AWS (1960) Fenacetin i relation til nyrefunktion. Ugeskr Laeger 122:856–860

    Google Scholar 

  259. Sorensen AWS (1961) Fenacetin consumption in relation to 24-hour endogenous creatinine clearance. Scand J Clin Lab Invest 13:337–340

    Google Scholar 

  260. Sorensen AWS (1966) Is the relation between analgesics and renal disease coincidental and not causal? Nephron 3:366–376

    PubMed  Google Scholar 

  261. Spühler O (1953) Probleme der interstitiellen Nephritis. Schweiz Med Wochenschr 83:145–148

    Google Scholar 

  262. Spühler O, Zollinger HU (1953) Die chronisch-interstitielle Nephritis. Z Klin Med 151:1–50

    PubMed  Google Scholar 

  263. Stachura I, Jayakumar S, Bourke E (1983) T and B lymphocyte subsets in fenoprofen nephropathy. Am J Med 75:9–16

    Google Scholar 

  264. Steele TW, Edwards KDG (1971) Aalgesic nephropathy; changes in various parameters of renal function following cessation of analgesic abuse. Med J Aust 1:181–187

    PubMed  Google Scholar 

  265. Studer A, Zbinden G (1955) Experimenteller Beitrag von Nierenschäden bei Abusus von phenanzetinhaltigen Schmerzmitteln. Experientia 11:450–451

    PubMed  Google Scholar 

  266. Studer A, Zbinden G, Fust B (1958) Weitere tierexperimentelle Untersuchungen zur Frage Schmerzmittelmißbrauch und interstitielle Nephritis. Schweiz Med Wochenschr 88:469–470

    PubMed  Google Scholar 

  267. Taylor JS (1972) Carcinoma of the urinary tract and analgesic abuse. Med J Aust 1:407–409, 1972

    PubMed  Google Scholar 

  268. The Coronary Drug Project Research Group (1976) Aspirin in coronary heart disease. J Chron Dis 29:625–642

    Google Scholar 

  269. Thiele KG, Muehrcke RC, Berning H (1967) Nierenerkrankungen durch Medikamente. Dtsch Med Wochenschr 92:1632–1635

    PubMed  Google Scholar 

  270. Thölen H (1954) Interstitielle Nephritis. Schweiz Med Wochenschr 84:963–967

    PubMed  Google Scholar 

  271. Thölen H, Voegtli J, Renschler H, Schaeffer A (1956) Ein Beitrag zur Genese der interstitiellen Nephritis. Schweiz Med Wochenschr 86:946–949

    PubMed  Google Scholar 

  272. Thölen H, Voegtli J, Renschler H, Schaeffer A (1956) Ein Beitrag zur Genese der interstitiellen Nephritis. Schweiz Med Wochenschr 86:978–981

    PubMed  Google Scholar 

  273. Vanherweghem J-L, Even-Adin D (1982) Epidemiology of analgesic nephropathy in Belgium. Clin Nephrol 17:129–133

    PubMed  Google Scholar 

  274. Viau C, Bernard A, Lauwerys R, Maldague P (1984) Cadmium, analgesics, and the chronic progressive nephrosis in the female Sprague-Dawley rat. Arch Toxicol 55:247–249

    PubMed  Google Scholar 

  275. Vivaldi E (1968) Effect of chronic administration of analgesics on resistance to experimental infection of the urinary tract in rats. Nephron 5:202–209

    PubMed  Google Scholar 

  276. Waters WE, Elwood PC, Asscher AW (1973) Community survey of analgesic consumption and kidney function in women. Lancet I:341–344

    Google Scholar 

  277. Wilson DR (1972) II. Analgesic nephropathy in Canada: a retrospective study of 351 cases. Can Med Assoc J 107:752–755

    PubMed  Google Scholar 

  278. Wilson DR, Gault MH (1982) Declining incidence of analgesic nephropathy in Canada. Can Med Assoc J 15:500–502

    Google Scholar 

  279. Wing AJ, Broyer M, Brunner FP, Brynger H, Challah S, Sonckerwolcke RA, Gretz N, Jacobs C, Kramer P, Selwood NH (1983) Combined report on regular dialysis and transplantation in Europe, XIII, 1982. Proc EDTA 20:5–78

    Google Scholar 

  280. Wiseman EH, Reinert H (1975) Anti-inflammatory drugs and renal papillary necrosis. Agents Actions 5:322–325

    PubMed  Google Scholar 

  281. Wolf H, Kluge H (1960) Zu Problemen des Schmerz- und Schlafmittelverbrauches. Dtsch Gesundh 17:1112–1120

    Google Scholar 

  282. Woodard G, Post KF, Cockrell KO, Cronin MTI (1965) Phenacetin: long-term studies in rats and dogs. Toxicol Appl Pharmacol 7:503

    Google Scholar 

  283. Zenser TV, Mattammal MB, Rapp NS, Davis BB (1983) Effect of aspirin on metabolism of acetaminophen and benzidine by renal inner medulla prostaglandin hydroperoxidase. J Lab Clin Invest 101:58–65

    Google Scholar 

  284. Zollinger HU, Spühler O (1950) Die nicht-eitrige, chronische interstitielle Nephritis. Schweiz Z Allg Pathol 13:807–811

    Google Scholar 

  285. Zollinger HU (1955) Chronische intersitielle Nephritis bei Abusus von phenacetinhaltigen Analgetica (Saridon usw.). Schweiz Med Wochenschr 85:746

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Innere Medizin, Klinikum Steglitz, Freie Universität Berlin, Germany

    A. Schwarz

Authors
  1. A. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwarz, A. Analgesic-associated nephropathy. Klin Wochenschr 65, 1–16 (1987). https://doi.org/10.1007/BF01785520

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01785520

Key words

Search

Navigation